搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
7 小时
SFA Therapeutics Strengthens Intellectual Property in Autoimmune Disease and Hepatocellular ...
SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...
11 小时
重医附二院脂质研究中心教授团队发表原发性肝癌研究新成果
人民网重庆10月22日电 近日,重庆医科大学附属第二医院(以下简称“重医附二院”)脂质研究中心丁银元特聘教授团队在国际知名期刊《Advanced Science》(中国科学院一区TOP期刊)上发表了题为“Loss of LRP1 Promotes ...
Too Old to Operate
15 小时
Medical Fiction: Lilith & the Secret Clinic
In this medical fiction tale, a journalist's attempt to expose what he believes to be a secret gender-affirming care clinic in a hospital basement turns deadly.
Targeted Oncology
1 天
FDA Accepts NDA Resubmission of Rivoceranib and Camrelizumab in HCC
The new drug application resubmission of rivoceranib/camrelizumab in the first line in unresectable or metastatic ...
healthandpharma
1 天
Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer
Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...
腾讯网
1 天
【Nature子刊】郑州大学郭文治团队:有前景的肝癌预后评估生物标志 ...
【导读】肝细胞癌(HCC)是肝脏最常见的恶性肿瘤,预后不佳。跨膜蛋白209(TMEM209)参与多种生物学过程,如物质转运和信号转导,在肿瘤组织中大量表达。然而,TMEM209与HCC之间的关系尚未完全阐明。10月16日,郑州大学郭文治研究团队在期刊 ...
Augusta Free Press
1 天
VCU: $13M grant helps scientists work to change the way liver cancer is treated
A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.
Medindia
3 天
Biomarker NBR1 Identifies Likely Immunotherapy Response in Liver Cancer
Biomarker NBR1 shows promise in predicting liver cancer patients' response to immunotherapy, potentially improving treatment ...
Medindia
3 天
Breakthrough in Liver Function Could Revolutionize Cardiovascular Care
Liver function discovery may pave the way for improved treatments of cardiovascular diseases, offering new insights into ...
Review
3 天
Review
Financial Analysis: TriSalus Life Sciences (TLSI) versus The Competition
TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) is one of 225 public companies in the “Surgical & medical instruments” ...
3 天
Liver cancer cases continue to rise in England, new data shows
Liver cancer cases continue to rise in England. This comes as NHS data, published this week, reveals a 5.4 percent increase ...
Armed robbery in Revesby
4 天
Biomarker May Predict Liver Cancer Immunotherapy Success
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈